Patent classifications
C12Y103/01024
METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IXβ reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.
METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IXβ reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.
METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IX reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.
Methods for increasing platelet count by inhibiting biliverdin IXβ reductase
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IX reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.
METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IX reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.
Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase C-delta and ERK related conditions
The present invention is directed to methods of modulating PKC- activity and PKC-/ERK complex activity in cells via biliverdin reductase. Methods and compositions for diagnosing and treating a PKC- and PKC-/ERK complex related condition are also disclosed.
METHODS FOR INCREASING PLATELET COUNT BY INHIBITING BILIVERDIN IXBETA REDUCTASE
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IX reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.